Cambridge Investment Research Advisors’s RPAR Risk Parity ETF RPAR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-10,073
Closed -$193K 3389
2023
Q4
$193K Sell
10,073
-239
-2% -$4.28K ﹤0.01% 2923
2023
Q3
$181K Buy
10,312
+24
+0.2% +$448 ﹤0.01% 2847
2023
Q2
$198K Sell
10,288
-4,397
-30% -$85.3K ﹤0.01% 2882
2023
Q1
$287K Buy
14,685
+11
+0.1% +$214 ﹤0.01% 2527
2022
Q4
$273K Sell
14,674
-2,363
-14% -$43.4K ﹤0.01% 2508
2022
Q3
$295K Buy
17,037
+42
+0.2% +$827 ﹤0.01% 2374
2022
Q2
$332K Sell
16,995
-13,182
-44% -$281K ﹤0.01% 2295
2022
Q1
$714K Buy
+30,177
New +$723K ﹤0.01% 1822
2021
Q4
Sell
-9,184
Closed -$222K 3257
2021
Q3
$222K Sell
9,184
-702
-7% -$17.4K ﹤0.01% 2722
2021
Q2
$241K Sell
9,886
-2,720
-22% -$64.7K ﹤0.01% 2657
2021
Q1
$286K Buy
12,606
+1,019
+9% +$23.9K ﹤0.01% 2315
2020
Q4
$276K Buy
+11,587
New +$264K ﹤0.01% 2217

Other funds holding RPAR

Cambridge Investment Research Advisors's RPAR Position: Q1 2024 in Review

Cambridge Investment Research Advisors sold out of RPAR Risk Parity ETF (RPAR) in Q1 2024, closing a stake of 10,073 shares — an estimated $193K sold.

Cambridge Investment Research Advisors first reported a position in RPAR in Q4 2020 and held it in 12 quarters. The position peaked at $714K in Q1 2022. 20 funds tracked by Wall St. Rank hold RPAR as of Q1 2024.

  • Cambridge Investment Research Advisors reported no remaining RPAR Risk Parity ETF position as of Q1 2024 after selling out during the quarter.
  • Cambridge Investment Research Advisors sold 10,073 RPAR Risk Parity ETF shares in Q1 2024, an estimated $193K.
  • Cambridge Investment Research Advisors first reported a position in RPAR Risk Parity ETF in Q4 2020 and held it in 12 quarters.
  • Cambridge Investment Research Advisors's RPAR Risk Parity ETF position peaked at $714K in Q1 2022.
  • 20 funds tracked by Wall St. Rank held RPAR Risk Parity ETF as of Q1 2024.

Based on Cambridge Investment Research Advisors's 13F filing for Q1 2024, filed 24 Apr 2024.